Search research articles
Contact Us
Filters
Showing results (521-530 of 549) with videos related to
Page
of 55
Sort By:
Advances in Biological Regulation
|
August 11, 2020
Cancer therapy and treatments during COVID-19 era
Shaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
British Journal of Haematology
|
November 16, 2011
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)
Sergio Amadori, Roberto Stasi, Alberto M Martelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2006
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey
L Pagano, A Gallamini, G Trapè, et al.
Advances in Biological Regulation
|
February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation
|
October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|
February 28, 2001
Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study
C M Martelli, M M Stefani, M K Gomes, et al.
Recenti Progressi in Medicina
|
April 29, 1998
[High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]
C Catassi, E Fabiani, G V Coppa, et al.
Biochimica Et Biophysica Acta
|
September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer
James A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Oncotarget
|
June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancer
James A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Blood
|
July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy
P L Zinzani, M Martelli, M Magagnoli, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 549) with videos related to
Sort By:
Page
of 55
Advances in Biological Regulation
|
August 11, 2020
Cancer therapy and treatments during COVID-19 era
Shaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
British Journal of Haematology
|
November 16, 2011
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)
Sergio Amadori, Roberto Stasi, Alberto M Martelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2006
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey
L Pagano, A Gallamini, G Trapè, et al.
Advances in Biological Regulation
|
February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation
|
October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|
February 28, 2001
Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study
C M Martelli, M M Stefani, M K Gomes, et al.
Recenti Progressi in Medicina
|
April 29, 1998
[High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]
C Catassi, E Fabiani, G V Coppa, et al.
Biochimica Et Biophysica Acta
|
September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer
James A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Oncotarget
|
June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancer
James A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Blood
|
July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy
P L Zinzani, M Martelli, M Magagnoli, et al.
Page
of 55